Director, Pennsylvania PACE Program National Medicare Congress

Slides:



Advertisements
Similar presentations
1 Filling the Holes in Part D: SPAPs to the Rescue? Marc Steinberg, Families USA Health Action 2005 * January 27,
Advertisements

Medicare and Prescription Drugs: Issues for Employers and Consumers Robert D. Reischauer The Urban Institute National Health Policy Conference January.
Challenges of Serving Low-income Medicare Beneficiaries: Impact of Cost Sharing Cindy Parks Thomas Brandeis University Schneider Institute for Health Policy.
Coordination of Benefits and TrOOP Tracey McCutcheon Center for Beneficiary Choices CMS.
2006 Retiree MIP Overview October 2006 Rajiv Nundy & Kent Humphries HR Compensation Management.
The Evolving Role of States in the Medicare Drug Benefit Thomas M. Snedden, Director Pennsylvania PACE Program The Third National Medicare Congress October.
Supplementing PACE through Medicare Part D
Pharmaceutical Assistance Contract for the Elderly (PACE) Program began July 1, 1984 PACE Needs Enhancement Tier (PACENET) Program began January 1, 1997.
Medicare Part D Nari Wang Health Law Unit 199 Water Street New York, NY Center for Independence of the Disabled, NY February 23, 2010.
North Carolina AIDS Drug Assistance Program (ADAP) State Pharmaceutical Assistance Program (SPAP)
Medicare Part D and HIV/AIDS: What a Clinician May Want to Know Laura Cheever, M.D., ScM Deputy Director, Chief Medical Officer HIV/AIDS Bureau Health.
— A Proposal to Cover All Americans —. 2 Health Coverage Passport Charles N. Kahn III President Federation of American Hospitals National Congress On.
Medicare and the New Prescription Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser.
Rutgers Center for State Health Policy June 28, 2005 Presentation to the Academy Health Kimberley Fox, Senior Policy Analyst Rutgers Center for State Health.
MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.
1 State Perspectives on Medicare Part D: Lessons from Pharmacy Plus Programs Cindy Parks Thomas Donald Shepard Christine E. Bishop Daniel M. Gilden Brandeis.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?
Medicare in Minnesota 2012 Your Medicare: Making the Best Possible Decisions October 2011 Presented by Stephanie Minor Senior LinkAge Line® Program Consultant.
Medicare Prescription Drug Benefit: Part D Health & Disability Advocates Stephanie Altman, J.D Ext
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Roy Trudel, CMSO National Eligibility Workers Association 07/12/05.
What’s in the Mail? Overview of Medicare Prescription Drug Coverage Beneficiary Communications Employer Forum Conference Call October 13, 2005.
MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy.
January National Medicare & You Training Program Amy Larrick, CMS NAACP April 27, 2006.
Introduction to Medicare and Medi-Cal for Seniors.
Medicare and Patient Assistance Sean M. Dougherty Senior Director Medicare Strategy & Patient Assistance Programs Government, Public Policy And Managed.
 The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27,
Impact of the MMA on Dual Eligible Beneficiaries and State Medicaid Programs Joy Johnson Wilson, Health Policy Director, NCSL June 28, 2005.
The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.
THE COMMONWEALTH FUND Medicare Part D: What Are The Concerns? Stuart Guterman Director, Program on Medicare’s Future The Commonwealth Fund Association.
11/8/051 Medicare Prescription Drug Benefits Employee Workshop November 2005.
Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.
Avalere Health LLC | The intersection of business strategy and public policy The Medicare Modernization Act: The Impact on States and Low-Income Beneficiaries.
Implications of the 2003 Medicare law for older adults and people with disabilities Translating “Legislative Sausage” into Understandable Choices Diane.
1 Cost Sharing for Low-Income Beneficiaries and Supplementing Part D Examples from Pharmacy Plus Medicaid Demonstration Programs Summit for State Health.
Karissa A. Laur Director, Prescription Assistance Programs Coordinating Patient Assistance Programs with Medicare Part D: A Manufacturer’s Perspective.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
National Conference of State Legislatures National Medicaid Congress June 5, 2006 State Pharmaceutical Assistance Programs, Medicaid & Part D: 2006 State.
Avalere Health LLC | The intersection of business strategy and public policy The Impact of Enrollment in the Medicare Prescription Drug Benefit on Premiums.
State Responses to Medicare Part D Presented by: Kimberley Fox, Senior Policy Analyst, Institute for Health Policy Academy Health Annual Research Meeting.
Overview of the Medicare Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser Family.
CL This material has been created or produced by CLAIM with financial assistance, in whole or part, through a grant from the Administration for.
Coordination of Benefits/Third Party Liability
Presenter: Mary McGeary
Health Coverage Enrollment in Michigan
Update on CMS Financial Alignment Initiative and State Integration Efforts Inside and Outside Demonstration Authority Lindsay Barnette Medicare-Medicaid.
Medicare and Medicaid Week 3.
MASSHEALTH: THE BASICS enrollment update as of march 2017
MASSHEALTH: THE BASICS enrollment update as of SEPTEMBER 2016
2018 Medicare Prescription Drug Benefit
Coordination of Benefits/Third Party Liability
MIPPA Programs Programs supported through the Medicare Improvements for Patients and Providers Act.
Medicare Enrollment, NOTES: Numbers may not sum to total due to rounding. People with disabilities under age 65 were not eligible for Medicare.
Health Coverage Enrollment in Michigan
Health Coverage Enrollment in Michigan
The Third National Medicare Congress David B. Snow, Jr.
Coordination of Benefits/Third Party Liability
Cost Sharing Under Part D: Impact on Beneficiaries with the Standard Benefit Bruce Stuart, PhD Director, Peter Lamy Center on Drug Therapy and Aging.
San Mateo County Uninsured Feasibility Analysis
Medicare and You John Williams SHIP Medicare Specialist
Medicare Part D: What Are The Concerns?
MEDICAID AND MMA ADMINISTRATIVE CHALLENGES: SPECIAL NEEDS PLANS
Coordination of Benefits/Third Party Liability
Medicare Rx Drug Benefit
Presented by Tricia Neuman, Sc.D.
Medicare Reform: Implications for Pharmaceutical Manufacturers
Medicare Part D Implementation Issues: Key Decisions for States
Medicare Made Clear Neither “We Speak Medicare” nor the presenting agent is connected with the Federal Medicare Program.
Stretching Your Health Care Dollars
SeniorCare Prescription drug coverage for Wisconsin residents age 65+
Presentation transcript:

Director, Pennsylvania PACE Program National Medicare Congress Coordinating the Medicare Modernization Act with State Pharmacy Assistance Programs: A State-Level Perspective Tom Snedden Director, Pennsylvania PACE Program ( tsnedden@state.pa.us ) National Medicare Congress Washington, DC November 2, 2005

State Senior Pharmacy Assistance Programs Comprehensive or catastrophic prescription medication benefit for qualified individuals Twenty-two states with programs ( Pennsylvania, New York, New Jersey, Michigan, Illinois & Connecticut) Collective enrollment of 1.8 million Many similarities in qualifying criteria and benefit structure Active states’ task force working on Medicare since February ‘03

Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE) Implemented 1984 Currently Serving 280,000 older Pennsylvanians Gross annualized expenditure of $480 Million Projected 2005 enrollment 335,000

Program Eligibility Criteria Sixty-five years of age or older Pennsylvania resident Limited income PACE =< $14,500 (Single) =< $17,700 (Married) PACENET =< $23,500 (Single) =< $31,500 (Married) Not enrolled in Medicaid Rx No asset test

The “PACE Cardholder” 79 years old widow four or five maintenance medications (anti-inflammatory, anti-platelet, osteoporosis treatment, lipid-lowering agent, and gastrointestinal agent) less than 10th grade education lives alone in a private residence

Medicare ’04-’05 Discount Card $600 annual Transitional Assistance(TA) Rx credit for Medicare beneficiaries with incomes less than 135% of FPL 151,000 PACE enrollees meet TA criteria (30,000 of which are also enrolled in Medicare HMO) PACE pharmacy benefit administrator (First Health) approved as Medicare card sponsor in effort to facilitate TA enrollment of qualified PACE enrollees PACE may “auto-enroll” TA eligibles, unless enrolled in Medicare HMO PACE pays TA coinsurance for its TA enrollees

Implications Saves PACE $150 million between June 1, 2004 and March 31, 2006 or 15% of gross outlay PACE “Auto-enrollment” of TA’s facilitates participation levels in Medicare Discount card program, particularly with respect to Medicare HMO enrollment of “exclusives.” Template for 2006 Medicare Part D Rx Benefit

PACE Comprehensive Rx benefit 195,000 enrollees $2,400 average annual Rx costs (per user) $333 paid by enrollee (14%) Open formulary Open pharmacy network Open enrollment

PACENET Catastrophic Rx benefit (monthly deductible) 98,000 enrollees $2,900 average annual Rx costs $940 paid by enrollee (32%) Open formulary Open network Open enrollment

Medicare Rx Full Subsidy Comprehensive Rx benefit Qualifying PACE enrollee pays $145 (6%) annually Estimated 80,000 PACE qualifiers Closed formulary Closed network Defined enrollment period Income (<135% FPL) and asset tests ($6,000 single/ $9,000 married) (Partial sliding subsidy available to persons with incomes between 135% and 150% FPL; estimated 20,000 PACE/PACENET qualifiers)

Medicare Rx Catastrophic Catastrophic Rx benefit (monthly premiums, annual deductible, 25% coinsurance and “donut hole”) Qualifying enrollee pays $1,965 (58%) annually All PACE/PACENET enrollees qualify Closed formulary Closed network Defined enrollment period

Options Eliminate PACE/PACENET “Wrap around” Part D Rx as qualified State Pharmacy Assistance Program (SPAP), coordinating benefit with as many as fifteen different plans Establish PACE/PACENET as a stand alone, “non-qualified” SPAP, enrolling nearly all cardholders in a single Part D plan

The claim pricing simulation included enrolled cardholders in either PACE or PACENET who had no breaks in coverage from 5/1/04-4/30/05 and who had one or more claims. Cardholders with third-party claims and Medicare discount plan claims were excluded, as were cardholders without utilization.